DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCORTISONE ACETATE; OXYTETRACYCLINE HYDROCHLORIDE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
HYDROCORTISONE ACETATE; OXYTETRACYCLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPOETIN ZETA
4
Protein
Approved
Unknown
Unknown
Diabetic Foot
Erythropoietin receptor agonist
EPOETIN ZETA
×
Maximum Phase:
4
First Approval:
None
UNII:
64FS3BFH5W
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASPIRIN; OMEPRAZOLE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
ASPIRIN; OMEPRAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABACAVIR;LAMIVUDINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ABACAVIR;LAMIVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ADALIMUMAB-BWWD
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ADALIMUMAB-BWWD
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
4
Combination
Approved
CARDIOVASCULAR; OTHER
ORAL
Unknown
Unknown
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GEMTUZUMAB
4
Antibody
Approved
Unknown
Unknown
Leukemia, Myeloid, Acute
Myeloid cell surface antigen CD33 binding agent
GEMTUZUMAB
×
Maximum Phase:
4
First Approval:
None
UNII:
93NS566KF7
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORMERODRIN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CHLORMERODRIN
×
Maximum Phase:
4
First Approval:
None
UNII:
99T5TWO621
Molecule Type:
Small molecule
Molecular Formula:
C5H11ClHgN2O2
Molecular Weight:
367.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DEXFENFLURAMINE
4
Small molecule
Approved
Unknown
Unknown
Obesity
Unknown
DEXFENFLURAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
E35R3G56OV
Molecule Type:
Small molecule
Molecular Formula:
C12H16F3N
Molecular Weight:
231.26
AlogP:
3.25
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
FLUSPIRILENE
4
Small molecule
Approved
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Schizophrenia; Psychotic Disorders
Unknown
FLUSPIRILENE
×
Maximum Phase:
4
First Approval:
None
UNII:
C5QA4GLR9M
Molecule Type:
Small molecule
Molecular Formula:
C29H31F2N3O
Molecular Weight:
475.58
AlogP:
5.31
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CLOTIAZEPAM
4
Small molecule
Approved
Unknown
Unknown
Anxiety
GABA-A receptor; anion channel positive allosteric modulator
CLOTIAZEPAM
×
Maximum Phase:
4
First Approval:
None
UNII:
ZCN055599V
Molecule Type:
Small molecule
Molecular Formula:
C16H15ClN2OS
Molecular Weight:
318.83
AlogP:
3.78
PSA:
32.67
HBD:
0.0
HBA:
#RotB:
2.0
Source:
FOLLITROPIN
4
Unknown
Unknown
Unknown
Unknown
Infertility, Male; Infertility; Hypogonadism; Primary Ovarian Insufficiency
Unknown
FOLLITROPIN
×
Maximum Phase:
4
First Approval:
None
UNII:
076WHW89TW
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; ZIDOVUDINE; ABACAVIR
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; ZIDOVUDINE; ABACAVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC 99M MEDRONATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM TC 99M MEDRONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
CH6O6P2Tc
Molecular Weight:
274.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
4
Combination
Approved
Unknown
INHALATION
Unknown
Unknown
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC 99M (PYRO- AND TRIMETA-) PHOSPHATES
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM TC 99M (PYRO- AND TRIMETA-) PHOSPHATES
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM MEDRONATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM MEDRONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
CH6O6P2Tc
Molecular Weight:
274.0
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LOFEPRAMINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
LOFEPRAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Z24K96F991
Molecule Type:
Small molecule
Molecular Formula:
C26H28Cl2N2O
Molecular Weight:
455.43
AlogP:
5.78
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
7.0
Source:
PADIMATE O
4
Small molecule
Approved
Unknown
Unknown
Melanosis
Unknown
PADIMATE O
×
Maximum Phase:
4
First Approval:
None
UNII:
Z11006CMUZ
Molecule Type:
Small molecule
Molecular Formula:
C17H27NO2
Molecular Weight:
277.41
AlogP:
4.13
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
8.0
Source:
POLYETHYLENE GLYCOL 4000
4
Small molecule
Approved
Unknown
Unknown
Blepharitis; Constipation; Diabetes Mellitus; Dry Eye Syndromes
Unknown
POLYETHYLENE GLYCOL 4000
×
Maximum Phase:
4
First Approval:
None
UNII:
4R4HFI6D95
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
4
Combination
Approved
OTHER
SUBCUTANEOUS
Unknown
Unknown
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
N-ACETYLCYSTINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
N-ACETYLCYSTINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMPACT
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
IMPACT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRASTUZUMAB; HYALURONIDASE-OYSK
4
Combination
Approved
Unknown
Unknown
Unknown
Unknown
TRASTUZUMAB; HYALURONIDASE-OYSK
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEFADROXIL/CEFADROXIL HEMIHYDRATE
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
CEFADROXIL/CEFADROXIL HEMIHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROSE BENGAL SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ROSE BENGAL SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
956575SN5L
Molecule Type:
Small molecule
Molecular Formula:
C20H2Cl4I4Na2O5
Molecular Weight:
1017.64
AlogP:
9.0
PSA:
87.74
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POTASSIUM BROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
POTASSIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
OSD78555ZM
Molecule Type:
Small molecule
Molecular Formula:
BrK
Molecular Weight:
119.0
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
POMX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
POMX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE
4
Combination
Approved
GASTROINTESTINAL; OTHER
CAPSULE; DELAYED REL PELLETS; ORAL
Unknown
Unknown
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROPOLIS
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PROPOLIS
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MOLSIDOMINE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
MOLSIDOMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
D46583G77X
Molecule Type:
Small molecule
Molecular Formula:
C9H14N4O4
Molecular Weight:
242.24
AlogP:
0.09
PSA:
82.78
HBD:
0.0
HBA:
#RotB:
3.0
Source:
1
2
…
251
252
253
254
255
256
257
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA